Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
J Int Med Res ; 50(3): 3000605221086146, 2022 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-35296168

RESUMEN

A 26-year-old man who had inhaled a dried pepper 7 years previously was admitted to our hospital for repeated coughing with yellow sputum and occasional hemoptysis. A thoracic high-resolution computed tomography scan revealed a foreign body at the proximal end of the right lower bronchus. We attempted to remove the foreign body by flexible bronchoscopy, but this was unsuccessful because the foreign body fell deeper into the bronchus. After a multidisciplinary team meeting, the foreign body was successfully extracted by bronchoscope suction and forceps under conscious sedation with spontaneous respiration. We avoided rigid bronchoscopy and traumatic surgery, thus decreasing the patient's risk and cost. We herein share our successful experience with this case.


Asunto(s)
Sedación Consciente , Cuerpos Extraños , Adulto , Bronquios/diagnóstico por imagen , Bronquios/cirugía , Broncoscopía , Sedación Consciente/efectos adversos , Cuerpos Extraños/diagnóstico por imagen , Cuerpos Extraños/cirugía , Humanos , Masculino , Respiración
2.
Endocr J ; 56(2): 201-11, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19008632

RESUMEN

OBJECTIVE: To investigate apoptosis in the thyroid of Graves disease (GD) induced by thyroid arterial embolization. MATERIALS AND METHODS: Forty one patients with clinically and laboratorily ascertained GD were treated with thyroid arterial embolization and followed up for 3-54 months following embolization. Prior to embolization and at 1, 3, 6, 12 and 36 months following embolization, thyroid autoimmunue antibodies were tested respectively, including thyroid stimulating antibody (TSAb), thyroglobulin antibody (TGAb) and thyroid microsomal antibody (TMAb). Thyroid biopsy was performed under the guidance of computed tomography for immunohistochemistry examination using semi-quantity analysis. RESULTS: The positive staining of Fas and FasL was mostly in the cytoplasma and cell membrane, the positive expression of Bax was mainly in the cytoplasma, and no positive expression of P53 was detected in the thyroid cells before embolization. After arterial embolziation, the positive cell number and staining degree of these genes were both greater than before embolization. CONCLUSION: The treatment method of thyroid arterial embolization can effectively enhance the positive expression of pro-apoptotic genes of Fas, FasL, Bax, Bcl-2 and P53 in GD thyroid, thus promoting apoptosis of GD thyroid and helping restore the thyroid size and function to normal conditions.


Asunto(s)
Apoptosis/inmunología , Embolización Terapéutica , Enfermedad de Graves/inmunología , Glándula Tiroides/inmunología , Adolescente , Adulto , Arterias , Autoanticuerpos/sangre , Proteína Ligando Fas/biosíntesis , Femenino , Expresión Génica , Enfermedad de Graves/fisiopatología , Enfermedad de Graves/terapia , Humanos , Masculino , Persona de Mediana Edad , Proteínas Proto-Oncogénicas c-bcl-2/biosíntesis , Glándula Tiroides/irrigación sanguínea , Hormonas Tiroideas/sangre , Proteína p53 Supresora de Tumor/biosíntesis , Proteína X Asociada a bcl-2/biosíntesis , Receptor fas/biosíntesis
3.
J Clin Immunol ; 28(5): 456-63, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18633697

RESUMEN

OBJECTIVE: The aim of this study was to investigate long-term immunological changes after the treatment of Graves' disease (GD) with thyroid arterial embolization and the effect of thyroid arterial embolization on the body's immunological functions. MATERIALS AND METHODS: Forty-one patients with clinically and laboratorily ascertained GD were treated with thyroid arterial embolization and followed up for 3-54 months following embolization. Prior to embolization and at 1, 3, 6, 12, and 36 months following embolization, thyroid autoimmune antibodies were tested respectively, including thyroid stimulating antibody (TSAb), thyrotropin antibody (TRAb), thyroglobulin antibody (TGAb), and thyroid microsomal antibody (TMAb), as well as subgroup lymphocytes of CD16+CD56+, CD19+, CD3+, CD3+CD4+ and CD3+CD8+. The autoimmune status of GD patients prior to embolization and the dynamic changes of the immunological function after embolization were analyzed. RESULTS: The therapy of thyroid arterial embolization could effectively decrease the activity/titer and positive rate of TRAb and the ratio of CD4+/ CD8+ to normal levels at 6 months following embolization, while the ratio of CD3+CD8+ increased gradually to normal level at 1 year following embolization. In patients with recurrence, TSAb and TRAb remained at a higher level, while the rate of CD3+CD8+ and the ratio of CD4+/CD8+ were not statistically significantly different from those before embolization. CONCLUSION: Immunological functional disorder exists in GD patients. The treatment method of thyroid arterial embolization can effectively resume the basic immunological function to normal range while patients with recurrence have no significant improvement, suggesting that thyroid arterial embolization has an effective role in adjusting the immunological function.


Asunto(s)
Embolización Terapéutica , Enfermedad de Graves/inmunología , Enfermedad de Graves/terapia , Inmunidad , Subgrupos de Linfocitos T/metabolismo , Adolescente , Adulto , Autoanticuerpos/sangre , Relación CD4-CD8 , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Enfermedad de Graves/sangre , Humanos , Inmunoglobulinas Estimulantes de la Tiroides/sangre , Inmunofenotipificación , Masculino , Persona de Mediana Edad , Monitorización Inmunológica , Recurrencia , Subgrupos de Linfocitos T/citología , Subgrupos de Linfocitos T/inmunología , Tiroglobulina/sangre , Tiroglobulina/inmunología , Tirotropina/sangre , Tirotropina/inmunología , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA